What’s Next for T-Cell Therapy and Avelumab for Merkel Cell Carcinoma

Description: Kelly Garneski Paulson, MD of Seattle Cancer Care Alliance discusses what's next in the future for her clinical trial on t-cell therapy and avelumab for merkel cell carcinoma at the 2017 ASCO Annual Meeting in Chicago, IL.
Shared By : AnnualMeeting2017
Posted on : 06/07/17
Added : 2 years ago